hotspot -WSS

hotspot

author：knowledge 2025-10-02 11:09:58 - browse：2

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： First Opinion Podcast: What happens when kids become caregivers?

WSS

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Focused ultrasound for uterine fibroids: an uphill battle

A rare thyroid diagnosis led to unexpected, all

Average age of first period drops to 11.9 years, study shows

Heat waves linked to early deliveries, preterm births in new study

AstraZeneca chief proposes a novel edit to the drug pricing bill

focus

hotspot

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

Stem cell treatment guidelines are released by FDA

United colonoscopy coverage change 'may cost lives,' doctors say

Startling documents reveal new facets of Sacklers' opioid empire

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Addiction doctors spar with methadone clinics over legislation

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

How to save PrEP access — and even expand it

Startling documents reveal new facets of Sacklers' opioid empire

Wikipedia

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

The (many) problems with a new study criticizing cancer screening

Advances in CAR

Addiction doctors spar with methadone clinics over legislation

Akili, maker of video game for ADHD, to be acquired for 34 million

Childbirth

entertainment

hotspot

focus

focus